Pfizer-BioNTech COVID-19 Vaccine was authorized on December 9, 2020, for use in accordance with the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 . Since the time of authorization, new information pertaining to dosage and administration, as well as to post-market adverse reactions, has been identified.
RecallTracker